MaxCyte, Inc.MXCTNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank77
3Y CAGR-8.0%
5Y CAGR+5.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-8.0%/yr
vs +27.7%/yr prior
5Y CAGR
+5.6%/yr
Recent deceleration
Acceleration
-35.7pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$34.42M-10.9%
2024$38.63M-6.4%
2023$41.29M-6.7%
2022$44.26M+30.6%
2021$33.89M+29.5%
2020$26.17M+21.0%
2019$21.62M+29.7%
2018$16.67M+19.2%
2017$13.98M+14.0%
2016$12.27M-